Psyence Group Inc.
PSYG
CNSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 229.24% | -109.57% | |||
| Depreciation & Amortization | 0.00% | -44.44% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 231.76% | -108.21% | |||
| Operating Income | -231.76% | 108.21% | |||
| Income Before Tax | -100.60% | 190.38% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -100.60% | 190.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -100.56% | 197.35% | |||
| EBIT | -231.76% | 108.21% | |||
| EBITDA | -231.76% | 108.21% | |||
| EPS Basic | -100.74% | 163.30% | |||
| Normalized Basic EPS | -106.47% | 224.60% | |||
| EPS Diluted | -100.74% | 163.30% | |||
| Normalized Diluted EPS | -106.47% | 224.60% | |||
| Average Basic Shares Outstanding | -25.06% | 53.82% | |||
| Average Diluted Shares Outstanding | -25.06% | 53.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||